Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease.
Fillit
H
H
The Alzheimer's Drug Discovery Foundation, NY, NY, USA.
Cummings
J
J
Neumann
P
P
McLaughlin
T
T
Salavtore
P
P
Leibman
C
C